Search

Your search keyword '"Fiorini, G"' showing total 487 results

Search Constraints

Start Over You searched for: Author "Fiorini, G" Remove constraint Author: "Fiorini, G"
487 results on '"Fiorini, G"'

Search Results

1. Evaluation of adherence to pharmacological treatments by undocumented migrants with chronic diseases: a 10-year retrospective cohort study

3. Characterizing non-communicable disease trends in undocumented migrants over a period of 10 years in Italy

6. Characterizing non-communicable disease trends in undocumented migrants over a period of 10 years in Italy

8. Ethnic, clinical, and pharmacological predictors of high social dependence in COVID-19 patients admitted to post-acute care

9. Healthcare Services for Undocumented Migrants: Organisation and Costs from the Italian NHS Perspective

10. A Cohort Study on Diabetic Undocumented Migrants in Italy: Can Charitable Organizations Contribute to Higher Adherence?

11. Pharmacological Treatment of Type-2-Diabetes and Cardiovascular Comorbidities: Differences between Undocumented Migrants and Natives in Italy

12. Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients

13. Ethnic, clinical, and pharmacological predictors of high social dependence in COVID-19 patients admitted to post-acute care

14. Effects of SARS-CoV-2 pandemic on follow-up and pharmacological treatment of chronic diseases in undocumented migrants

15. Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)

17. Undocumented migrants during the covid-19 pandemic: Socio-economic determinants, clinical features and pharmacological treatment

18. Severe impaired blood pressure control caused by baroreflex failure as a late sequela of neck irradiation

19. Current pharmacological treatment of type 2 diabetes mellitus in undocumented migrants: Is it appropriate for the phenotype of the disease?

20. European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

21. COVID-19 vaccine hesitancy among undocumented migrants during the early phase of the vaccination campaign: A multicentric cross-sectional study

22. Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg)

23. Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy

25. OC.08.5 EFFECTIVENESS OF EMPIRICAL SECOND-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

26. OC.08.4 ANTIBIOTIC RESISTANCE TRENDS OF ITALIAN H. PYLORI NAÏVE PATIENTS BETWEEN 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

27. AF.24 CHARACTERISTICS OF EMPIRICAL FIRST- AND SECOND-LINE TREATMENT BETWEEN 2013-2020: ITALIAN DATA FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

29. OC.08.2 EFFECTIVENESS OF EMPIRICAL FIRST-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT (HP-EUREG)

30. Multi-centric assessment of COVID-19 immunization access and demand among undocumented migrants

31. European Registry on Helicobacter pylori management (Hp-EuReg): Patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients

32. Impact of Helicobacter pylori clarithromycin resistance on the treatment effectiveness: data of the European registry on H. pylori management (HP- EUREG)

33. Helicobacter pylori antibiotic resistance: data from the European registry on H. pylori management (HP-EUREG)

34. MORPHOMETRIC SURVEYS ON ELEOCHARIS PALUSTRIS (L.) ROEM. ET SCHULT. (CYPERACEAE). THE CONTRIBUTION OF HERBARIUM INVESTIGATIONS TO THE DELIMITATION OF ITS SUBSPECIES AND THEIR DISTRIBUTION IN ITALY

35. Antibiotic resistance trends of Helicobacter pylori naïve patients in the period 2013-2019: analysis of the European registry on H. pylori management (HP-EUREG)

36. First line H. pylori eradication therapy in Europe: results from 24,882 cases of the European registry on H. pylori management (HP-EUREG)

37. T02.01.18 USE OF PROBIOTICS IN THE HELICOBACTER PYLORI ERADICATION IN ITALY: DATA FROM THE “ITALIAN REGISTRY” ON H. PYLORI TREATMENT

39. An algorithm to identify patients with type 2 diabetes mellitus among undocumented migrants using data on drugs dispensation by charities: A pilot study

40. Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment

41. Correction for potentially inappropriate prescribing can increase specificity when using drug prescriptions as an adjunct to diagnostic codes to assess comorbidities in older patients

42. Biases in palliative care access for elderly patients dying in hospital: A prospective study in acute care

49. Gender and age related differences in the use of medicines for chronic diseases among undocumented migrants

Catalog

Books, media, physical & digital resources